Wenbin Jiang, President and CEO at Cytek Biosciences, Inc. (CTKB), sold 20,000 shares at $5.33 ($107K) on 2023-10-09, disclosed to the SEC on 2023-10-11.
Scheduled sale ($107k) by President and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| CTKB | SELL | 2023-08-08 | $362K | — | Filing → |
| CTKB | SELL | 2023-07-07 | $170K | — | Filing → |
| CTKB | SELL | 2023-06-07 | $165K | — | Filing → |